<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title><![CDATA[RSS for King Pharmaceuticals]]></title>
<description><![CDATA[Watch breaking news videos and read news updates about King Pharmaceuticals on FOXBusiness.com.]]></description>
<link><![CDATA[http://www.foxbusiness.com/search-results/]]></link>
<atom:link xmlns:atom="http://www.w3.org/2005/Atom" type="application/rss+xml" rel="self" href="http://www.foxbusiness.com/search-results/urss?pageid=174115"/>
<item>
<title><![CDATA[Pfizer Has Second Recall of Thyroid-Disorder Drug Levoxyl]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/10/pfizer-has-second-recall-thyroid-disorder-drug-levoxyl/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/10/pfizer-has-second-recall-thyroid-disorder-drug-levoxyl/</guid>
<pubDate><![CDATA[Fri, 10 May 2013 16:52:13 EDT]]></pubDate>
<description><![CDATA[Pfizer Inc. (PFE) issued its second recall of thyroid-disease treatment Levoxyl in recent weeks, this time because some tablets didn't meet potency standards.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Pfizer Recalls Thyroid-Disorder Drug Over Odor Problem]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/03/pfizer-recalls-thyroid-disorder-drug-over-odor-problem/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/03/pfizer-recalls-thyroid-disorder-drug-over-odor-problem/</guid>
<pubDate><![CDATA[Wed, 03 Apr 2013 18:05:01 EDT]]></pubDate>
<description><![CDATA[Pfizer Inc. (PFE) has recalled about 52,000 bottles of thyroid-disease treatment Levoxyl because of complaints of uncharacteristic odors in some bottles.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Protecting Your Portfolio From a Soft Patch]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/981459120001/protecting-your-portfolio-from-a-soft-patch/?]]></link>
<guid>http://video.foxbusiness.com/v/981459120001/protecting-your-portfolio-from-a-soft-patch/</guid>
<pubDate><![CDATA[Tue, 07 Jun 2011 12:20:23 EDT]]></pubDate>
<description><![CDATA[Morgan Stanley Smith Barney Chief Investment Strategist David Darst on why the economy and markets are facing a soft patch, but not a full-fledged double-dip recession.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/060711/640/360/060711_closing_darst.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Pfizer Buying King Pharma for $3.6B]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/4370563/pfizer-buying-king-pharma-for-36b/?]]></link>
<guid>http://video.foxbusiness.com/v/4370563/pfizer-buying-king-pharma-for-36b/</guid>
<pubDate><![CDATA[Tue, 12 Oct 2010 10:21:45 EDT]]></pubDate>
<description><![CDATA[FBN's Shibani Joshi on Pfizer's acquisition of the pharmaceutical company.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/101210/640/360/101210_fbb_brief1000_FBN_101210_10-04.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Daily Mail Reports L'Oreal Set to Bid on Avon Products]]></title>
<link><![CDATA[http://video.foxbusiness.com/v/4370508/daily-mail-reports-loreal-set-to-bid-on-avon-products/?]]></link>
<guid>http://video.foxbusiness.com/v/4370508/daily-mail-reports-loreal-set-to-bid-on-avon-products/</guid>
<pubDate><![CDATA[Tue, 12 Oct 2010 09:26:18 EDT]]></pubDate>
<description><![CDATA[FBN's Connell McShane on the potential acquisition of the cosmetics company.]]></description>
<media:thumbnail>http://video.foxbusiness.com/thumbnails/101210/640/360/101210_fbb_brief900_FBN_101210_09-10.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Early-Market Movers: King Pharmaceuticals, Synaptics Inc.]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2010/10/12/early-market-movers-king-pharmaceuticals-synaptics/?]]></link>
<guid>http://www.foxbusiness.com/markets/2010/10/12/early-market-movers-king-pharmaceuticals-synaptics/</guid>
<pubDate><![CDATA[Tue, 12 Oct 2010 08:58:58 EDT]]></pubDate>
<description><![CDATA[Here are some early-market movers for Tuesday.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Pfizer to Buy King Pharma for $3.6 Billion in Cash]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2010/10/12/pfizer-buy-king-pharma-billion-cash/?]]></link>
<guid>http://www.foxbusiness.com/markets/2010/10/12/pfizer-buy-king-pharma-billion-cash/</guid>
<pubDate><![CDATA[Tue, 12 Oct 2010 08:35:04 EDT]]></pubDate>
<description><![CDATA[Pfizer said Tuesday that the $14.25 per share deal for King would amount to a 40 percent premium over the company's closing share price on Monday.]]></description>
<media:thumbnail/>
</item>
</channel>
</rss>
